Goserelin acetate 2 mg | 100.00%
TargetMol
Goserelin acetate is a synthetic long-acting agonist of gonadotropin-releasing hormone, used in treatments of cancer.
More Information Supplier PageGoserelin acetate
Search Results
HZ-1157 1 mg | 98.23%
TargetMol
HZ-1157 is a hepatitis C virus (HCV) inhibitor with inhibitory activities toward HCV NS3/4A protease.
More Information Supplier PageHZ-1157
rac-BHFF 50 mg | 100.00%
TargetMol
Rac-BHFF is potent and selective GABA B receptor positive allosteric modulator that increases the potency and efficacy of GABA ( > 15-fold and > 149% respectively). It exhibits anxiolytic activity in vivo and is orally active.
More Information Supplier Pagerac-BHFF
rac-BHFF 10 mg | 100.00%
TargetMol
Rac-BHFF is potent and selective GABA B receptor positive allosteric modulator that increases the potency and efficacy of GABA ( > 15-fold and > 149% respectively). It exhibits anxiolytic activity in vivo and is orally active.
More Information Supplier Pagerac-BHFF
Blarcamesine hydrochloride 25 mg | 99.95%
TargetMol
Blarcamesine hydrochloride (AVex-73 hydrochloride) is a Sigma-1 Receptor agonist (IC50: 860 nM).
More Information Supplier PageBlarcamesine hydrochloride
Blarcamesine hydrochloride 2 mg | 99.95%
TargetMol
Blarcamesine hydrochloride (AVex-73 hydrochloride) is a Sigma-1 Receptor agonist (IC50: 860 nM).
More Information Supplier PageBlarcamesine hydrochloride
Goserelin acetate 100 mg | 100.00%
TargetMol
Goserelin acetate is a synthetic long-acting agonist of gonadotropin-releasing hormone, used in treatments of cancer.
More Information Supplier PageGoserelin acetate 25 mg | 100.00%
TargetMol
Goserelin acetate is a synthetic long-acting agonist of gonadotropin-releasing hormone, used in treatments of cancer.
More Information Supplier PageGoserelin acetate
Amcasertib 25 mg | Purity Not Available
TargetMol
Amcasertib is an orally administered investigational agent designed to inhibit cancer stem cell pathways via targeting stemness kinases.
More Information Supplier PageAmcasertib
Amcasertib 1 mg | Purity Not Available
TargetMol
Amcasertib is an orally administered investigational agent designed to inhibit cancer stem cell pathways via targeting stemness kinases.
More Information Supplier PageAmcasertib